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LDL oxidation and oxidative stress are closely related to atherosclerosis. Therefore, natural antioxidants 
have been studied as promising candidates. In the present study, the LDL oxidation inhibition activity 
of bioactive compounds from Halimeda incrassata seaweed. associated to antioxidant capacity, was 
evaluated in vitro. Experimental work was conducted with lyophilized aqueous extract and phenolic-rich 
fractions of the seaweed and their effect on LDL oxidation was evaluated using heparin-precipitated 
LDL (hep-LDL) with exposure to Cu2+ ions and AAPH as the free radical generator. H. incrassata had a 
protective effect for hep-LDL in both systems and the presence of phenolic compounds contributed to the 
activity where phenolic-rich fractions showed significant capacity for inhibition of oxidation mediated by 
Cu2+ ions. The observed effect could be related to the antioxidant potential of polar fractions evidenced 
by reducing activity and DPPH• radical scavenging. The results obtained in vitro further support the 
antioxidant and LDL oxidation inhibition properties of H. incrassata and further knowledge toward 
future phytotherapeutic application of the seaweed.
Uniterms: Halimeda incrassata/antioxidant properties. Antioxidants. Polyphenols. Lipoproteins/
oxidation inhibition.
A oxidação da LDL e o estresse oxidativo estão intimamente relacionados com a aterosclerose. Por 
isso, os antioxidantes naturais têm sido estudados como candidatos promissores. No presente trabalho 
foi avaliada in vitro a capacidade de inibição da oxidação da LDL pelos compostos bioativos da alga 
Halimeda incrassata em associação à capacidade antioxidante. O trabalho experimental foi conduzido 
com extratos polares (extrato aquoso liofilizado e frações ricas em fenólicos) e seu efeito na oxidação 
da LDL foi avaliado usando LDL precipitada com heparina (hep-LDL), oxidada com íons de Cu2+ e 
AAPH, como geradores de radicais livres. A H. incrassata apresentou efeito protetor para hep-LDL em 
ambos sistemas e a presença de compostos fenólicos contribuiu para a atividade em que as frações ricas 
em fenólicos demonstram capacidade significativa em inibir a oxidação mediada pelos íons de Cu2+. O 
efeito observado deve estar relacionado com o potencial antioxidante das frações polares medido pela 
atividade redutora e varredura do radical DPPH. Os resultados obtidos demonstram as propriedades 
antioxidantes e de inibição da oxidação da LDL da H. incrassata e podem contribuir para as evidências 
de futuras aplicações fitoterapêuticas desta alga.
Unitermos: Halimeda incrassata/propriedades antioxidantes. Antioxidantes. Polifenóis. Lipoproteínas/
inibição da oxidação.
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INTRODUCTION
Atherosclerosis is a complex multifactorial disease 
characterized by modification and oxidation of lipopro-
teins that, together with a chronic inflammatory response 
in the artery wall, leads to atherosclerotic lesions (Fernán-
dez-Britto, 1998). LDL oxidation and oxidative stress 
are closely related to atherosclerosis. Therefore, natural 
antioxidants have been studied as promising candidates 
(Vogiatzi et al., 2009; Kaliora et al., 2006).
Oxidative modifications have been shown to be in-
volved in all stages of atherosclerosis progression so anti-
oxidants from natural sources are of interest in the quest for 
antiatherogenic activity. In this respect, edible seaweeds are 
an excellent source of antioxidants that have been evaluated 
for cardiovascular health and for their beneficial properties 
(Jimenez-Escrig et al., 2001; Bocanegra et al., 2009).
Seaweed extracts are presently regarded as an at-
tractive source of natural antioxidants as they have highly 
developed antioxidant defence systems that have provided 
evolutionary advantage for sea survive in stressful envi-
ronmental conditions. Their wide array of antioxidants 
such as mycosporine-derived aminoacids, polysaccharides, 
carotenoids, terpenoids and phenolic compounds could be 
beneficial for human health (Jiménez-Escrig et al., 2001; 
Kang et al., 2003). Indeed, decreased mortality from car-
diovascular diseases in Asian populations could be linked 
to seaweed consumption (Bocanegra et al., 2009).
It has been shown in previous studies that H. incras-
sata has a high phenolic content (Vidal et al., 2011), together 
with low amounts of other antioxidants such as ascorbate, 
β-carotene, chlorophylls and selenium. The quantity of hy-
drophilic phenolics found in this seaweed lies in the same 
range as other seaweeds reported in the literature and also 
studied by our group (Jiménez-Escrig et al., 2001; Yoshie et 
al., 2002; Vidal et al., 2001). The cardioprotective properties 
of phenolic compounds from different food types have been 
described by several authors (Kaliora et al., 2006; Aviram et 
al., 2008) with particular interest in the unique antioxidant 
combination found in marine algae that is not found in ter-
restrial plants (Kang et al., 2003; Chan et al., 2006).
In the present study, the capacity of H. incrassata 
for the inhibition of LDL oxidation owing to its phenolic 
content and antioxidant activity was evaluated in vitro.
MATERIAL AND METHODS
Seaweed collection and hydrophilic extract 
preparation
The seaweed Halimeda incrassata (Ellis) Lamour-
oux was collected in December/2010 in the Bajo de Santa 
Ana, Havana City coast, Cuba. Voucher specimens were 
authenticated at the Seaweeds Laboratory of the Marine 
Research Center of the University of Havana. Freshly 
collected specimens were washed with distilled water and 
dried at room temperature for seven days. An analytical 
mill and a sieve with a 32 mesh were used for milling and 
sieving, respectively. The dry powder was used to obtain 
polar extracts. Dry seaweed powder was extracted with 
distilled water (1:5 w/v) for 1 hour under agitation at room 
temperature and then centrifuged at 800 g and 4 ºC for 
20 minutes. Supernatant was recovered, lyophilized and 
kept at -20 ºC until use. Weight yield of the final extract 
in terms of dry seaweed was 6%. The lyophilized material 
was dissolved in distilled water at a known concentration 
for the study.
Polyphenolic rich fractions were obtained according 
to Krygier et al., (1982). Free phenolic acids (FPA) were 
extracted six times, each into 20 mL of tetrahydrofurane 
(THF), using a separatory funnel. The combined extract 
was then evaporated to dryness under vacuum at room 
temperature. With the residue of the previous extraction, 
and through extractions with methanol:acetone:water, the 
aqueous solution and residue were obtained. The aqueous 
solution was neutralized and residue dissolved in 20 mL 
of 2 M NaOH and hydrolyzed for 4 h at room temperature 
under a stream of nitrogen. After acidification to pH 2 (us-
ing 6 M HCl), phenolic acids liberated from esters were 
extracted five times, each into 20 mL of tetrahydrofurane: 
ethylether:ethyl acetate, using a separatory funnel. The 
combined extracts were then evaporated to dryness. The 
dry residues of of soluble esters of phenolic acids (SEPA) 
and of insoluble esters of phenolic acids (IEPA) were 
obtained and dissolved separately in 5 mL of methanol.
Total phenolic concentration
Total phenolic content was determined by the 
Folin-Ciocalteau assay (Quettier-Deleu et al., 2000) and 
expressed as µg of gallic acid equivalents (GAE) /gram of 
sample. The calibration curve was obtained in the range 
of 100 - 1000 µg gallic acid /mL.
Reducing power
Reducing power of the seaweed phenolic-rich frac-
tions was evaluated according to Oyaizu (1986) with 
minor modifications. A 1 mL sample (10 - 360 μg GAE) 
was mixed with 2.5 mL phosphate buffer (0.2 M, pH 6.6) 
and 2.5 mL 1% K3Fe(CN)6 and incubated at 50 ºC for 20 
minutes. After cooling, 2.5 mL 10% TCA was added and 
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centrifugation was done at 800 g for 10 minutes. 2.5 mL 
aliquots were taken from the upper layer and 0.5 mL of 
0.1% FeCl3 with 2.5 mL distilled water were added for the 
final reaction. Absorbance was read at 720 nm on a Ray-
leigh VIS-723G device against a water blank. Increments 
in absorbance were considered as increases in reducing 
power. 
DPPH• radical scavenging assay
Free radical scavenging activity of H. incrassata 
extract was examined by the DPPH• assay. DPPH• radical 
absorbance capacity of H. incrassata polyphenol-rich frac-
tions was tested according to Goupy et al. (1999). A 0.6 mL 
volume of the extract (10 - 40 μg GAE) was mixed with 
0.6 mL of methanolic solution of DPPH• (60 μM). After 
30 minutes, absorbance was measured at 517 nm against 
a sample without antioxidant. Radical scavenging activity 
was calculated relative to reference absorption as Percent-
age Inhibition (PI) (%) = [1-Asample/Asample without antioxidant] × 
100. Results were given as % antioxidant activity and 50% 
inhibitory concentration (IC50).
In vitro inhibition of LDL oxidation in cell-free 
system
Oxidation experiments were conducted with hep-
arin-precipitated LDL (hep-LDL), a model of LDL that 
has interacted with extracellular matrix and is therefore 
more prone to oxidation (Upritchard, Sutherland, 1999). 
Lipoproteins were isolated from normolipemic human 
serum by the method of Wieland (1983). A 5 mL volume 
of sodium citrate buffer (64 mmol/L, pH 5.12) containing 
heparin (50 000 UI/L) was added to 0.5 mL serum. After 
incubating for 10 minutes at room temperature, the sample 
was centrifuged at 800 g for 15 minutes. Hep-LDL precipi-
tate was washed 3 times with Hepes buffer (5 mM Hepes, 
20 mM NaCl, 4 mM CaCl2 and 2 mM MgCl2, pH 7.2), by 
centrifuging at 800 g for 15 minutes, hep-LDL was next 
dissolved in 0.5 mL phosphate buffer, pH 7.4, with NaCl 
4 %. The Hep-LDL fraction was then divided into aliquots 
and kept at 4 ºC. Cholesterol content was determined by 
enzymatic assay (Boehringer Mannhein Diagnostics) and 
protein content by the Lowry method (1951). 
To evaluate the action of the extracts against LDL 
oxidation and determine the contribution of the bioactive 
compounds present in it, experiments were first done with 
the lyophilized aqueous extract, a more crude extract con-
taining algae component. 
The hep-LDL oxidation assay was done using LDL 
(0.2 μmol cholesterol) diluted in phosphate buffer and 
incubated in the presence or absence of H. incrassata 
lyophilized aqueous extract for 6 hours at 37 oC with 
10 μM Cu2+ or 20 mM AAPH. Inhibitory activity against 
lipoperoxidation of the phenolic-rich FPA, SEPA and IEPA 
fractions was evaluated based on Cu2+ mediated hep-LDL 
oxidation. The oxidation was determined by thiobarbituric 
reactive substances (TBARS) as described in Frostegard 
et al. (1990) and expressed as nmoles MDA equivalents/ 
mg protein, using tetramethoxypropane (TMP) as the 
standard. Results are expressed as percentage of inhibition 
of lipoperoxidation.
RESULTS
Phenolic content of hydrophilic fractions of H. 
incrassate
Phenolic content in aqueous extract and fractions 
FPA, SEPA and IEPA of H.incrassata are shown in Table I.
Reducing power of polar fractions of H. incrassata
There was an increment in reducing power with 
increasing phenolic content of the polar extracts with 
values of absorbance - OD of around 0.16 at 30 μg GAE 
and highest absorbance (nearly 1.2) reached at 360 µg 
GAE (Figure 1).
DPPH• radical scavenging capacity of polar 
fractions
The polar fractions had concentration-dependent 
free radical scavenging activity in the DPPH• assay with 
more than 50% inhibition at a concentration of 40 µg 
polyphenols (Figure 2). 
TABLE I - Phenolic content (µg total phenolics/g dry seaweed) 
in polar fractions obtained from seaweed Halimeda incrassata. 
Fraction µg GAE/g dry seaweed
FPA 14.16 ± 0.92
SEPA 9.91 ± 0.81
IEPA 11.06 ± 4.2
aqueous extract 130.98 ± 8.04
Total phenolic content expressed as μg of gallic acid equivalents 
(GAE)/gram dry seaweed. Legend: FPA - Free phenolic acids; 
SEPA - Soluble esters of phenolic acids; IEPA - Insoluble esters 
of phenolic acids. Values expressed as mean ± s.d. (n=3).
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In vitro inhibition of LDL oxidation in cell-free 
system
Inhibition of LDL oxidation was dose-dependent for 
both Cu2+ ions and AAPH mediated oxidation on addition 
of H. incrassata lyophilized aqueous extract (0.6 - 10 mg/
mL) as indicated in Figure 3. 
Similarly, the mean inhibitory concentration (IC50) 
for n-LDL (native LDL) and hep-LDL oxidation mediated 
by Cu2+ and AAPH is shown in Table II.
The three polar fractions rich in phenolic compounds 
(FPA, SEPA and IEPA) were also active against hep-LDL 
oxidation mediated by Cu2+ ions with more than 50% inhi-
FIGURE 1 - Reducing capacity of polar fractions of Halimeda 
incrassata. Reducing power of the polar fractions was evaluated 
at concentrations of 10 - 360 µg polyphenols and the assay was 
performed according to Oyaizu et al., (1986). Values expressed 
as mean ± s.d. (n=3). 
FIGURE 2 - DPPH• radical scavenging activity of polar fractions 
of Halimeda incrassata seaweed. The assay was performed 
as described by Goupy et al., 1999. Results were given as % 
antioxidant activity and 50 % inhibitory concentration (IC50). 
Values represent mean ± s.d. (n=3).
FIGURE 3 - Dose-response curves of the aqueous extract 
of Halimeda incrassata on inhibition of lipoperoxidation in 
hep-LDL oxidation mediated by Cu2+ 10 µM (A) or AAPH 
20 mM (B). H. incrassata concentration is expressed in 
log concentration of aqueous extract (1 mg lyophilized is 
equivalent to 0.02 g dry seaweed containing 2.183 ± 0.134 µg 
GAE/mg lyophilized aqueous extract. Values represent mean 
± s.d. (n=3).
TABLE II - Effect of Halimeda incrassata on LDL oxidation in 
cell free systems. 
50 % mean inhibitory concentration 
(IC50) of H. incrassata (mg/mL)
Cell-free systems Cu 2+ AAPH
Hep-LDL 3. 747 ± 0.106 1.222 ± 0.1196
n-LDL 0.875 ± 0.0962 0.161 ± 0.014
Results expressed in mg/mL where 1 mg lyophilized is 
equivalent to 0.02 g dry seaweed containing 2.183 ± 0.134 µg 
GAE/mg lyophilized aqueous extract and values represent mean 
± s.d. (n=3). Legend: Hep-LDL (heparin-precipitated LDL) and 
n-LDL (native LDL)
Inhibition of LDL-oxidation and antioxidant properties related to polyphenol content of hydrophilic fractions 35
bition of TBARS formation at 20 µg polyphenols (Figure 
4) indicating that phenolic compounds are relevant in pro-
tection against lipoperoxidation exerted by H. incrassata.
DISCUSSION
Phenolic content has been correlated to the antioxi-
dant capacity of several seaweed extracts (Jiménez-Escrig 
et al., 2001; Senevirathne et al., 2006). Values of phenolic 
contents of H. incrassata obtained were 9.99-14.1 and 131 
µg GAE/g dry seaweeds for phenolic rich fractions and 
aqueous extract, respectively. The values for these frac-
tions proved higher than those reported for others varieties 
of seaweeds, but are consistent with the levels found in 
F.vesiculosus and B.triquetrum (Jiménez-Escrig et al., 2001; 
Vidal et al., 2001). It had been previously reported that 
FPA, SEPA and IEPA fractions and aqueous extract from 
H.incrassata were rich in phenolic acids (Vidal et al., 2011).
The relevance of hydrophilic phenolics was also 
emphasized by other authors (Senevirathne et al., 2006) 
who showed that reducing capacity and DPPH• scaveng-
ing increased with solvent polarity and phenolic content 
in seven fractions of the seaweed E. cava. In the present 
study, a dose-dependent reducing activity and DPPH• 
scavenging (Figures 1 and 2) was obtained with increas-
ing phenolic content for the evaluated polar extracts 
(r2 = 0.69 for reducing power and r2 = 0.77 for DPPH• 
radical scavenging).
Likewise, a similar reducing activity was obtained 
by Cho et al. (2007) with the seaweed S. siliquastrum 
which had an absorbance of 0.8 at a lower phenolic content 
than the phenolic rich-fractions of our study (240 μg EAG 
vs 360 µg EAG). 
FIGURE 4 - Inhibitory activity of phenolic-rich polar fractions 
in hep-LDL oxidation mediated by Cu2+ done according to 
Frostegard et al. (1990). Oxidation was conducted in the 
presence of the fractions FPA, SEPA and IEPA from seaweed 
Halimeda incrassata and evaluated by TBARS formation. 
Values expressed as mean ± s.d.
Interestingly, both for reducing capacity and DPPH• 
radical scavenging (IC50= 29.42 to 39.17 versus 0.75 µg 
polyphenols, respectively) there was a higher activity for 
the aqueous extract than for the phenolic-rich fractions 
showing that other antioxidant components present in 
H. incrassata could have a synergic action with phenolic 
compounds.
In vitro inhibition of LDL oxidation was evaluated. 
The assays were done with heparin precipitated LDL, with 
Cu2+ ions and AAPH used as oxidants to model transition 
metal or free radical mediated oxidation respectively. In 
LDL oxidation experiments (Figures 3 and 4) there was 
a more advanced degree of oxidation in the presence of 
Cu2+ than for AAPH as the oxidant (causing formation of 
28.4 nmol MDA/mg protein versus 14.5 nmol MDA/mg 
protein as oxidation products respectively). Indeed oxi-
dation mediated by Cu2+ is considered a more aggressive 
system that transits through Cu2+ binding, causing continu-
ous free radical formation with reduction of lipoprotein 
antioxidants; whereas oxidation by AAPH is a simpler 
model that ignores the influence of transition metals (Pin-
chuk and Lichtenberg, 2002). Accordingly, the aqueous 
extract had inhibitory action in both, where attaining a 
protective effect required higher doses for transition metal-
mediated oxidation compared with free radical oxidation 
(IC50 = 3.747 versus 1.222 mg/mL). 
Also, it should be noted that, in comparison to our 
previous studies on native LDL oxidation, higher doses of 
aqueous extract were required to protect hep-LDL consis-
tent with their higher susceptibility to oxidation compared 
to n-LDL (IC50 = 0.875 and 0.161 for Cu2+ and AAPH as 
inductor, respectively). 
The effect of H. incrassata can be compared to that 
found for other extracts in the literature with 0.5-1 mg/mL 
needed to inhibit Cu2+ ion-mediated LDL oxidation in 
the case of P.quinquefolium, a ginseng variant (Li et al., 
1999) and 0.2 mg/mL causing 18.7 % inhibition of TBARs 
formation for VNP, a commercial product prepared from 
a mixture of several brown seaweeds (Kang et al., 2003).
The influence of seaweed phenolics on inhibition 
of lipoprotein oxidation was evaluated (Figure 4). The 
Cu2+ ions-induced hep-LDL oxidation inhibition activity 
found (100% for 40µg of polyphenols) for the fractions 
(FPA, SEPA and IEPA) supports the protective effect of 
the seaweed and indicates that phenolic compounds of H. 
incrassata contribute to the inhibition of LDL oxidation. 
In this study, a positive correlation was confirmed 
between DPPH• radical scavenging and inhibition of 
LDL oxidation for phenolic rich fractions (r2 = 0.92 for 
the FPA fraction) indicating that free radical scavenging 
is a mechanism involved in inhibition of lipoperoxida-
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tion mediated by the seaweed. Our group has previously 
highlighted the relevance of free radical scavenging for 
antilipid peroxidative activity (Rivero et al., 2003). 
Other authors have studied the action of natural 
phenolic compounds in the inhibition of LDL oxidation. 
Aviram et al. (2008), studying antiatherogenic properties 
of pomegranate juice, found that significant inhibition of 
TBARs formation during LDL oxidation was achieved 
at 0.5 μg GAE. In another study on the antiatherogenic 
properties of olive oil polyphenols Rosenblat et al. (2007) 
found 80 % inhibition of oxidation at 1.2 μg GAE for olive 
oil, whereas when enriched with tea polyphenols the ef-
fect obtained was enhanced, correlating with an increase 
in phenolic content.
CONCLUSIONS
The results of this study indicated that H. incras-
sata polar extracts have properties for inhibition of LDL 
oxidation that could be related to high antioxidant activ-
ity evaluated as reducing capacity and scavenging of free 
radicals. Seaweed phenolic compounds could be the main 
components involved in the antioxidant and antilipid per-
oxidative action, although small quantities of other anti-
oxidants present could have a synergic effect and enhance 
LDL oxidation inhibition activity. Additionally, these 
results represent a further step toward its application as a 
phytotherapeutic for oxidative stress-related conditions.
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